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Pe!nphigus vulgaris antigen is in the cadherin super-
gene family. We hypothesized that the extracellular 
dO!nain of pemphigus vulgaris antigen !night mediate 
homophilic cell adhesion because 1) the originally de-
scribed cadherins (e.g., E-cadherin) !nediate this type 
of adhesion, 2) pemphigus vulgaris antigen is localized 
in desmosomes that are cell adhesion junctions, and 3) 
autoantibodies in pemphigus vulgaris patients cause 
loss of cell adhesion. To test this hypothesis we used a 
system developed for E-cadherin that, when trans-
fected into L cells (mouse fibroblasts), has been shown 
to cause aggregation. Because this aggregation re-
quires the cytoplasmic domain of E-cadherin to bind 
to catenins, we made a chimeric eDNA construct that 
encodes the extracellular domain of pemphigus vul-
garis antigen and the cytoplasmic domain of E-cad-
herin. Analysis by immunofluorescence and flow cy-
tome try with pemphigus vulgaris sera indicated that 
the pemphigus vulgaris antigen extracellular domain 
Pemphigus vulgaris is a skin disease in which autoanti-bodies cause loss of epidermal cell-to-cell adhesion with resultant blister formation [1]. Cloning of the cDNA encoding pemphigus vulgaris antigen (PVA) with auto-antibodies from these patients revealed that it is a mem-
ber of the cadherin supergene family [2]. The originally described or 
classical cadherins (e.g. , E-cadherin, N-cadherin, P-cadherin) have 
been shown to be calcium-dependent homophilic adhesion mole-
cules [3]. However, PV A is actually more closely related to the 
desmogleins, which are also in the cadherin supergene family, than 
to the classical cadherins [2,4]. Desmoglein was originally defined 
as a transmembrane glycoprotein found in the desmosome, a cell-
to-cell adhesion junction [4] . At least two genes encode desmogleins 
(DSG 1 and DSG2); the PVA gene is now termed DSG3, and, siI?i-
lady, PV A is also called desmoglein 3 [5,6]. Furthermore, PV A, like 
the other desmogleins, has been shown to be localized in desmo-
somes [7] . Although in the cadherin supergene family, desmogleins 
have not been shown to mediate homophilic adhesion. 
We hypothesized that PVA could mediate homophilic cell-to-
cell adhesion based on the findings discussed above, namely, 1) in 
pemphigus vulgaris patients autoantibodies against PVA cause loss 
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of this chimeric molecule (PVEC) was expressed on 
the cell surface of transiently transfected cells and per-
manently transfected L-cell clones. Immunoprecipita-
tion of the chimeric molecule from extracts of these 
clones showed that the E-cadherin cytoplasIIlic do-
main bound catenins. Surprisingly, these L-cell clones 
displayed only slight aggregation compared to an L-
cell clone transfected with E-cadherin. This weak ag-
gregation was, however, specific and homophilic, as 
deterIIlined by cell sorting of only PVEC transfectants 
into aggregates from mixtures ofPVEC and neomycin 
resistance gene transfectants, one of which was labeled 
with a fluorescent dye. We conclude that the extracel-
lular dO!nain of pe!nphigus vulgaris antigen Dlediates 
weak hODlophilic adhesion and is not interchangeable 
in function with the extracellular dODlain of E-cad-
herin. Key words: desmosome/cadherin/autoimmune/ca-
tenino ReprintedfromJ Invest DermatoI102:402-408, 1994 
of adhesion [8], 2) PV A is closely related to classical cadherins both 
in overall amino acid sequence and in specific sequences that are 
putative functional sites in adhesion and calcium-binding [2] , and 3) 
PV A is found in cell adhesion junctions [7]. 
Classical cadherins have been shown to mediate cell adhesion by 
transfection of their cDNA into L cells that are mouse fibroblasts 
that do not normally express cadherins [9 -11). However, to medi-
ate cell adhesion the cytoplasmic domain of these cadherins must be 
intact. Even when the extracellular domain of cadherins is expressed 
on th~ c~1I surface it does not mediate adhesion if the cytoplasmic 
domam IS severely truncated [12,13] . The cytoplasmic domain of 
cadherin binds to the actin cytoskeleton through molecules called 
catenins [13,14). a-, /3-, and y-catenins are present in L cells and 
presumably permit the cadherins to function properly, perhaps by 
clustering the molecules in intercellular contact sites associated with 
the actin cytoskeleton [1 2,13,15]. In this regard a-catenin seems to 
be the key linking molecule, although /3-catenin is bound most 
tightly to the cadherin [13,15]. Studies of L cells transfected with 
cDNAs altered by site-directed mutagenesis of the intracellular re-
gion ofE-cadherin show that only those constructs capable of bind-
ing both a - and /3-catenin, or perhaps /3-catenin alone, function in 
homophilic adhesion, suggesting that this cytoplasmic binding is 
necessary for function [13 ,16]. y-catenin, on the other hand, is the 
most loosely associated with the cadherin-catenin complex and is 
sometimes difficult to detect [13,15). Its importance in cadherin 
function is uncertain. 
The cytoplasmic tail of PV A, like the other desmogleins, binds 
only to plakoglobin (which co-migrates on sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) with y-catenin, 
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Figure 1. Construction of chimeric cDNA that encodes the extracel-
lular domain of PV A and the transmembrane and cytoplasmic do-
mains of E-cadherin. The Noti-DralI restriction enzyme fragment of 
PYA cDNA was ligated to a PCR productthat spanncd the coding region for 
the E-cadherin (E-cad) transmembrane and cytoplasmic domain. A DralI 
restriction site was added to the upstream PCR primer and an Xbal site to the 
downstream primer. The ligated product was then cloned into the eukary-
otic expression vector pcDNA1 at a Notl-Xbal site. Hatched box and solid box 
indicate sequences encoding transmembrane regions. 
but is probably a distinct protein [17,18]) and does not bind to ex- or 
fJ-catenin [19]. Thus, the cytoplasmic tail of PyA might not func-
tion in L cells. Therefore, to test the possible adhesive function of 
the extracellular domain of PYA we transfected L cells with a chi-
meric cDNA encoding the extracellular domain of PYA and the 
cytoplasmic domain of E-cadherin, which is known to function in 
these cells. We speculated that this binding of ex- and fJ-catenin by 
the cytoplasmic tail of the chimeric molecule (called PVEC) might 
be necessary for the extracellular domain of PYA to function prop-
erly. We show here that, although the PYA extracellular domain is 
expressed on the cell surface of the transfected L cells and the PVEC 
cytoplasmic domain binds catenins in the same way as the cytoplas-
mic domain of E-cad herin, PVEC mediates only weak homophilic 
binding when compared to that due to E-cadherin. 
MATERIALS AND METHODS 
cDNA Constructs The nucleotide sequence and numbering of the PV A 
cDNA and E-cadherin cDNA are as published [2,9]. Eukaryotic expression 
vectors, driven by the p-actin promoter, with eDNA encoding neomycin 
resistance (pBATneo) or mouse E-cadherin (pBATEM2) were provided by 
Masatoshi Takeichi [11]. PV eDNA containing the full-length coding se-
quence was obtained by joining the previously cloned 5' PV cDNA (E33) 
with the previously cloned 3' PYA eDNA (E12) at a common Xbal site at 
nucleotide 1085 [2,8] . The chimeric eDNA (called PVEC cDNA), encoding 
the extracellular domain of PYA and the transmembrane plus cytoplasmic 
region of E-cadherin was constructed as shown in Fig 1. The NotI-DraII 
fragment of the PYA eDNA was ligated to a Drall site engineered into a 
polymerase chain reaction (PCR) product of the E-cadherin eDNA. This 
PCR product was amplified with primers that spanned the nucleotides en-
coding the transmembrane region and cytoplasmic domain of E-cadherin. 
The PVEC chimeric cON A was then dircctionally subcloned into the CMV 
promoter-driven eukaryotic expression vector pcDNAl (Invitrogen Corp., 
San Diego, CAl in a Notl -Xbal site. N ucleotide sequences of this construct 
revea led two mutations, one at nucleotide 397 of the PV A coding sequence 
and one at nucleotide 2396 of the E-cadherin coding region. Both of these 
mutations terminated the open reading frame, therefore they were replaced. 
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The former was corrected with a PCR product of non-mutated PYA cDNA 
from the 5' Notl site to a Sail site at nucleotide 426. The latter was replaced 
with an Xmal-BpHI fragment from the E-cadherin eDNA. The final con-
struct was totally sequenced and shown to have only one base change (a G to 
an A at position 2483 of the chimeric construct) that did not change the 
amino acid sequence. 
Transient and Permanent Transfections COS-7 cells and L cells 
(ATCC CCL 1.1) were obtained from American Type Culture Collection 
(Rockville, MD). To determine if the chimeric PVEC protein was trans-
ported to, and expressed on, the cell surface, we transiently transfected 
COS-7 and L cells with Lipofectin (GIBCO-BRL, Gaithersburg, MD) ac-
cording to the manufacturer's directions. Approximately 5 I1g of the chi-
meric PVEC cDNA construct in pcDNAl was used per 6 cm dish of cel ls. 
To obtain permanent L-cell transfectants we used Lipofectin or calcium 
phosphate transfection systems (GIBCO-BRL) with 5-15 I1g of PVEC 
cDNA in pcDNAl or E-cadherin cDNA construct pBATEM2 with 0.511g 
of pBATneo in 6 cm dishes. Two days after transfection ce lls were cultured 
in 400 I1g/ml of G418 (GIBCO-BRL). After 10 - 12 d individual G418-re-
sistant colonies were selected with cloning rings. 
Immunologic Characterization ofTransfected Cells PV and bullous 
pemphigoid sera were obtained from patients w ith clinically, histo logically, 
and immunohistologica lly characteristic disease. ECCD-2, a rat monoclonal 
IgG against mouse E-cadherin [20], was a gift from Masatoshi Takeichi, as 
was PCD-1, a rat monoclonal IgG against P-cadherin, used as a control [21]. 
To detect the extracellular domain of PV A on the surface of transiently 
transfected COS-7 and L ce ll s, we performed immunofluorescence with PV 
sera (or normal control sera) and fluorescein isothiocyanate (FITC)-
conjugated goat anti-human IgG on living cells as previously described [22J. 
We also analyzed permanently transfected L cell clones by flow cytometry. 
Single cell suspensions were prepared with t mM ethy lenediaminetetraace-
tic acid (EDTA) in 10 mM Hepes-buffered calcium- and magnesium-free 
Hanks' balanced salt solution (GIBCO-BRL). 2 X volume of washing buffer 
(10% feta l bovine serum, 1 mM CaCl2 , 0.02% sodium azide in Hepes-buf-
fered Hanks' solution) with 10 I1g/ml deoxyribonuclease I (GIBCO-BRL) 
was added and cells were suspended at 5 X 1 OS/200 111 in washing buffer. ALI 
subsequent washes and antibody incubations were performed at 4 'C. Cells 
were incubated for 60 min in 20 ttl of a 1:20 to 1:50 dilution (in washing 
buffer) of pemphigus vulgaris, bullous pemphigoid, or normal sera; washed 
twice; and incubated for 30 min with 20111 of a 1 :40 dilution ofFITC-conju-
gated F(ab'l, goat anti -human IgG (Tago, Burlingame, CAl. Cells were 
washed three times, re-suspended in 1 ml washing buffer containing 10 
flg/m] deoxyribonuclease I for analysis on a FACScan flow cytometer (Bec-
ton Dickinson). Propidium iodide-permeable dead cells were gated out. 
To detect synthesis of the PVEC chimeric molecule we used immuno-
blotting ofSDS extracts oftransfected L cell clones [2]. Extracts of HAC AT 
cells (a spontaneously transformed human keratinocyte line kindly provided 
by Dr. Norbert Fusenig) were used as a positive control for detection ofPVA. 
To demonstrate the binding of the cytoplasmic domain of E-cadherin to 
catenins, we metabolically labeled transfected L-cell clones with 35S-meth-
ionine/cysteine (NEN Express, D upont, Boston, MA) for 18 h [7] . Radiola-
belled cells were extracted with 1 % Nonidet P-40, 1 % Triton X-lOO, 2 mM 
CaCl2, 150 mM N aCI in 10 mM Tris-HCl, pH 7.4, with protease inhibitors 
(aprotinin 2l1g/ml, leupeptin 2l1g/ml, pepstatin 1l1g/ml, PMSF 1 mM). 
Aliquots of celllysates containing approximately 60 X 106 cpm were preab-
sorbed with normal human serum (for immunoprecipitates performed with 
PV sera) or normal rat serum (for immunoprecipitates performed with 
ECCD-2) and protein G sepharose (Sigma Chemical Co., St. Louis, MO), 
then precipitated with 10111 ofpV serum (or bullous pemphigoid serum used 
as a control) or ECCD-2, approximately 10 I1g (or PCD-l used as a control), 
and protein G, as previously described [7] . Immunoprecipitates were eluted 
from protein G with SDS sample buffer and resolved by SDS-PAGE [7]. 
Aggregation Assay Single ce ll suspensions of transfected L-cell clones 
were obtained with EDT A as described above. Cel ls were then washed twice 
in Hepes-buffered Hanks' solution with 10 I1g/ml deoxyribonuclease I and 
10% FBS in the first wash. Cells were re-suspended in Hepes-buffered 
Hank's solution with 10 I1g/ml deoxyribonuclease I and 1 mM CaCI2• In 
some experiments t % bovine serum albumin, 10% feta l bovine serum, 2 
mM MgCl2, or excess ethylene glycol bis-(fJ-aminoethyl ether) 
N,N,N'-tetraacetic acid (EGTA) was added. Approximately 5 X 105 cells 
per 2.5 ml were incubated in 35 mm dishes (precoated with 2% bovine serum 
albumin at 37"C for 2 h) with gentle shaking (approximately one revolution 
persecend) at 37 ° for 1 to 3.5 h, then incubated at room temperature without 
shaking for up to 24 h before being viewed with an inverted phase-contrast 
microscope. In some experiments we assessed the abi lity of two different 
transfected clones to self-aggregate (i .e., sort) by labeling one with the 
fluorescent dye 5-carboxyfluorescein diacetate (Molecular Probes, Eugene, 
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Figure 2. Cell surface expression of PV A on PVEC transf~ctants. 
Immunofluorescence with PV sera demonstrates cell surface sta1lung of a 
subpopulation of COS-7 (A) and L cells (B) transiently rransfected with 
PVEC cDNA. Scale bar, 25 J.l.m (A) , 40 J.l.m (B) . 
OR) at a concentration of 10 - 12.5 J.l.M at room temperature for 10 min 
(from a stock solution of 10 mM in dimethylsulfoxide). 
RESULTS 
characterization of the Chimeric PVEC cDNA Construct 
A chimeric cDNA encoding the extracellular domain of PYA and 
the transmembrane and cytoplasmic region of E-cadherin was con-
structed using a Notl-Drall restriction fragment of the PYA cDNA 
and a PCR product that spanned the nucleotides encoding the trans-
membrane region and cytoplasmic domain of E-cadherin (Fig 1). 
This product was cloned into pcDNA1, a eukaryotic expression 
vector driven by a CMV promoter. 
To demonstrate that this construct could be successfully tran-
scribed and translated in eukaryotic cells and that the protein prod-
uct could be expressed on the cell surface in the proper orientation, 
we transiently transfected COS-7 cells and stained living cells by 
immunofluorescence with pemphigus vu lgaris sera. Approximately 
5% of cells showed cell surface staining with five of five pemphigus 
vulgaris sera, demonstrating that the PVEC protein is transported to 
the cell membrane with the PV A extracellular domain exposed (Fig 
2A). Similar staining was not seen w ith five bullous pemphigoid 
sera and one normal human serum. In addition, COS-7 cells trans-
fected with a PVEC construct that had a stop codon at nucleotide 
397 did not stain with PV sera. Because we wanted to use the PVEC 
construct for permanent transfection of L cel ls, we performed simi-
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Figure 3. PVEC clones express the chimeric protein. Immunoblots of 
extracts of L-cell clones PVEC32, PVECll, neop1, and ncoP2 with PV 
serum show that the clones transfected with the PVEC cON A (PVEC32 and 
PVEC11) express the chimeric protein (arrow). For comparison is an extract 
of HACAT cel ls (H) which show the 130-kD PYA. 
lar immunofluorescence studies on L-cell transient transfectants 
with similar results (Fig 2B). 
Characterization of Permanently Transfected L-Cell Clones 
L cells, which are mouse fibroblasts lacking cadherins, were co-
transfected with pBATneo (encoding for neomycin resistance) plus 
eukaryotic expression vectors containillg either the PVEC construct 
or an E-cadherin construct (pBATEM2). Transfected clones were 
selected in G418. 
Immunoblotting of extracts of PVEC cDNA-transfected clones 
w~s performed to determine which clones synthesized PVEC pro-
tem. In some clones, PV sera detected a specific band of the expected 
molecular weight (approximately 120 kD), less than that of PYA 
it~elf (~pproximately 130 kD) because of the shorter cytoplasmic 
tall (Flg 3). Extracts of control clones transfected with pBATneo 
alone did not show staining of this band with PV sera. Two clones, 
PVEC11 and PVEC32, were selected for further characterization 
because they showed the largest amounts of the chimeric molecule 
on these immunoblots. 
To demonstrate that the extracellular domain of PV A was ex-
pressed on the cell surface of these clones, we used flow cytometric 
analysis with PV sera. PVEC cDNA-transfected clones PVECII 
and PVEC32, but not clones transfected only with pBATneo 
(clones neofJ1 and neofJ2), showed cell surface fluorescence with PV 
sera, but not control bullous pemphigoid sera (Fig 4). PVEC11 and 
PVEC32 showed approximately equal amounts of cel l surface fluo-
rescence, consistent with the immunoblotting data. An L-cell clone 
(LECS) transfected with a eukaryotic expression vector encoding 
mouse E-cadherin (pBATEM2) also showed cell surface staining 
with ECCD-2, an anti-mouse E-cadherin monoclonal antibody, but 
not with a control monoclonal antibody, by flow-cytometric analy-
sis (data not shown; [23]). 
To demonstrate that the cytoplasmic domain of E-cadherin re-
tained the ability to bind catenins in the context of the PVEC chi-
meric molecule, we metabolically labeled PVECll and PVEC32 
and used PV sera for immunoprecipitation analysis. These studies 
demonstrated that the catenins were co-precipitated with the chi-
meric PVEC molecule (Fig 5). These co-precipitated caten.ins co-
migrated with the catenins co-precipitated with full length E-cad-
herin from LECS cells (Fig 5). 
In addition, approximately equal amounts of radiolabeled caten-
ins were co-precipitated from extracts of both PVEC clones and the 
LECS clone. (Sequential immunoprecipitation analysis indicated 
that the first immunoprecipitate contained essentially all the pre-
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Figure 4. Extracellular PV A domain is expressed on the cell surface 
ofL-cell clones transfected with the PVEC chimeric eDNA. PV sera 
and bullous pemphigoid (BP) control sera were used for f1ow-cytometric 
analysis of clones PVEC 11, PVEC32, and control clones neop1 and neofJ2. 
cipitable material [data not shown]). These r.esults indicate that ap-
proximately the same molar amount of catenm-bound PVEC mole-
cules and E-cadherin were expressed in the PVEC cells and the 
LECS cells, respectively, because the cytoplasmic domain ofE-cad-
herin binds catenins in a fixed molar ratio [1S]. 
In sum, these data demonstrate that PVEC clones express the 
chimeric PVEC molecule in the proper orientation and that the 
cytoplasmic domain is functionally equivalent to that present in 
LECS cells. We, therefore, used these clones to compare the aggre-
gation potential of PVEC transfectants t~ that ~f E-cadheri~ trans-
fectants. This would be expected to proVide a direct companson of 
PV PV uE B P PV uP 
11 32 LEC 32 ~2 LEC 
Figure 5. E-cadherin cytoplasmic domain in the PVEC chimeric 
molecule binds to catenins. Extracts of clones PVECl1 (11), PVEC32 
(32) , LECS (LEe), and control clone neop2 (/12) were subjected to immuno-
precipitation with pemphigus vulgaris (PV) serum, bullous pemphigoid 
serum (BP) as a control, ECCD-2 anti-E-cadherin antibody (0£), and/or 
PCD-1 anti-P-cadherin antibody (aP) as a control. Arrow, E-cadherin; 
broke,! arrow, PVEC chimeric molecule; closed arrowhead, a-catenin; opw 
arrowhead, p-catenin. 
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the PV A extracellular domain and the E-cadherin extracellular do-
main in which both have the same cytoplasmic domain that is capa-
ble of binding catenins. 
PYA Extracellular Domain Mediates Weak Homophilic 
Adhesion The morphology of the PVEC transfectants was no 
different from that of the neomycin-resistance transfectants or un-
transfected L cells. In contrast, the E-cadherin transfectant clone 
(LECS) showed a more epithelioid morphology as has been previ-
ously reported [9]. 
In our first attempts at assaying the aggregation potential of 
transfected L cells, we used conditions developed for E-cadherin 
[11]. Single cell suspensions of transfected L cells, prepared with 
0.01 % trypsin/1 mM CaCI2 , were allowed to re-aggregate in 1 mM 
calcium. With these conditions, E-cadherin is not degraded and will 
function in cell aggregation; however, we saw no aggregation of 
PVEC transfectants (Fig 6A). Subsequently we determined by flow 
cytometric and immunoprecipitation analysis that, unlike E-cad-
herin, the extracellular domain of PV A, both on PVEC transfec-
tants and keratinocytes, is degraded by trypsin/calcium treatment 
( unpublished observations). 
We therefore modified the conditions of the aggregation assay to 
remove cells from the culture dish into single cell suspensions with 
1 mM EDT A. With these conditions, PVEC transfectants still ex-
pressed PYA on the surface as determined by flow-cytometric anal-
ysis (Fig 4). When these cells were allowed to re-aggregate in 1 
mM calcium we observed slight aggregation of PVECl1 and 
PVEC32 compared to very marked aggregation of LECS cells and 
little, if any, aggregation of neop1 and neop2 cells (Fig 6). Al-
though it was our general impression from microscopic examina-
tion of cell aggregates in 11 experiments that a subset of the 
PVEC11 and PVEC32 cells aggregated, the aggregation was too 
slight to be quantitated because most cells were not involved. In 
addition, the PVEC cell aggregates were loose with the individual 
cells well outlined compared to the very compact aggregates of 
LECS cells that had lost their cell outlines (Fig 6, compare C to B, 
D, and E). We tried varying conditions to enhance the aggregation. 
After detachment of cells we incubated with gentle shaking at 37°C 
from 1 h to 3.S h, then incubated cells without shaking at room 
temperature for up to 24 h . We found that aggregation could be 
seen best either after incubation at 37 °C for over 2 h or after the 
room temperature incubation for at least 1 h. However, under all 
conditions only a minority of the cells formed aggregates. Aggrega-
tion seemed somewhat calcium dependent, as less aggregation was 
seen when cells were incubated in the presence of EGTA (data not 
shown). 
To confirm that this aggregation of a subset of the PVEC trans-
fectants was related to the expression of the PV A extracellular do-
main we determined if it represented homophilic adhesion by doing 
cell-sorting experiments in which two different transfectants were 
mixed, one of which was labeled with a fluorescent dye. In mixtures 
of LECS and PVEC cells, the LECS cells showed strong aggrega-
tion and excluded the PVEC cells, demonstrating that E-cadherin 
mediates strong homophilic adhesion of LECS cells and that other 
cells do not become non-specifically incorporated into aggregates 
(Fig 7A,B). In mixtures of PVEC cells alone, in which half of the 
cells were labeled, aggregates showed both labeled and unlabeled 
cells, demonstrating that mixed aggregates could be detected with 
this method (Fig 7C,D). However, in mixtures ofPVEC cells and 
neop cells, the small, sporadic aggregates that formed consisted 
essentially only ofPVEC cells, showing that although the aggrega-
tion seen was weak it was specific for PV A expressing cells (Fig 
7E,F). 
DISCUSSION 
This study examines a direct comparison of the aggregation poten-
tial of the extracellular domains of PYA and E-cadherin when both 
are expressed in L cells and linked to the cytoplasmic catenins with 
the same (E-cadherin-derived) transmembrane and cytoplasmic 
domains. The results show that the extracellular domain of PV A 
mediates weak, but specific and homophilic, adhesion that is not 
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Figure 6. Aggregation assay of transfected L-cell clones. Except for A, cells were released from the culture dish with EDTA. A/ B and C/D/ E/ F, 
respectively, were aggregated under the same conditions at the same time. A) PVECll clone released from the substrate with 0.01 % trypsin/1 ruM CaCI2 does 
not show aggregation at 1 h. B) PVEC 11 clone released from the substrate with EDT A shows slight aggregation. C) LEC5 clone (transfected with E-cadherin) 
shows massive aggregation at 3.5 h. Note that cell borders are completely obscured. D) PVECl1 clone shows slight aggregation. E) PVEC32 clone shows 
slight aggregation. F) neofJ2 clone (trallsfected with only a neomycin resistance gene) does not show aggregation. Scale bar, 1251.1.m. 
nearly as effective as adhesion mediated by E-cadherin. Only a small 
subpopulation of cells expressing PV A aggregated, and those that 
did showed rather loose clumping, very different from the large 
tight aggregates, in which cell borders are obscured, produced by 
LEes cells. 
What could account for the weak aggregation of cells expressing 
the PYA extracellular domain compared to that ofE-cadherin? One 
possibility is that for cadherins to function properly they must bind 
the cytoskeleton. For E-cadherin this means that the cytoplasmic 
domain must bind actin filaments through its interaction with ca-
tenins [12]. To test the function of the PYA extracellular domain we 
expressed a chimeric molecule that had the cytoplasmic region of 
E-cadherin and we showed that this region functioned properly in 
the binding of catenins. If, as has been postulated, the cytoplasmic 
region of E-cadherin functions by clustering adhesion molecules 
then the E-cadherin cytoplasmic region should have functioned 
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Figure 7. PVEC aggregation, although slight, is specific. AlB, CID, and EIP, respectively, arc phase and fluorescence views of the same fields . Each set 
of fields shows mixing of two different clones, one of which was labeled with a fluorescent dye. A/B) LECS cells (unlabeled) and PVECll (labeled). Large 
aggregate of unlabeled cells do not incorporate labeled cells. CID) PVECll (labeled) mixed with PVEC32 (unlabeled) show aggregates consisting of both 
label ed and unlabeled cells. EIP) PVEC32 (unlabeled) and neofJ2 (labeled). Note that small aggregates consist of unlabeled cells (i.e., PVEC32 cells without 
neo/12 cells). Scale bar, 60 /1m. 
properly in clustering the extracellular domain of PYA. On the 
other hand, if the cytoplasmic region functions by changing the 
conformation of the extracellular portion of E-cadherin, it might 
not function properly for the extracellular region of PYA. How-
ever, it is thought to be unlikely that the cytoplasmic domain of 
E-cadherin actually could effect its extracellular structure because 
lack of this domain does not change its biochemical properties that 
are presumably related to structure [12]. For the same reasons it is 
unlikely that the authentic PV A cytoplasmic tail would cause the 
extracellular domain ofpVA to function better. However this could 
not be tested directly because we have been unable to clone the 
full-length PYA cDNA due to mutations causing stop codons in the 
open reading frame whenever the full- length cDNA is cloned in 
bacteria (unpublished observation) . 
Another possibility for minimal function ofpVA in this system is 
that its level in PVEC transfectants might be insufficient. This 
seems unlikely because immunoprecipitation experiments indicated 
that the molar amounts of the catenin-bound PVEC chimeric mole-
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cule in PVEC clones and E-cadherin in the LECS clone is about the 
same. In addition, multiple PVEC clones did not show marked 
aggregation. However, it is possible that the small amount of aggre-
gation we did see was due to those cells showing particularly high 
expression within each clone. 
Improper folding , glycosylation, and/or proteolytic processing 
of the precursor molecule to the mature form are also theoretically 
possible to account for the weak adhesive function of the PYA 
extracellular domain in these transfectants. For example, site di-
rected mutagenesis aimed at the proteolytic cleavage site of uvo-
morulin prevents its processing to the mature form and also destroys 
its adhesive function [24] . However, in general, mammalian cells 
fold and glycosylate proteins similarly. In addition, the classical 
cadherins are properly folded and processed to functional molecules 
in these L cells [9-11,24]' therefore, it would be expected that PVEC 
would be similarly processed. Finally, PV A and classical cadherins 
have highly homologous proteolytic cleavage sites that are pre-
sumed to be processed by the same endogenous protease [2]. 
Another potential explanation for weak adhesion of PV A in this 
system is that our hypothesis that PV A functions in strong homo-
philic cell-co-cell adhesion might be incorrect. For instance, per-
haps PV A is involved instead in signal transduction when cells come 
together. However the observation that we did see weak and spe-
cific adhesion suggests that PV A does subserve this function, but we 
do not have the correct conditions for optimal function. 
We think the most likely reason that the extracellular domain of 
PV A did not function well in these tranfectants is that other mole-
cules, for example, other transmembrane and/or cytoplasmic des-
mosomal proteins, are necessary for proper function. It should also 
be considered that, if PV A does function in adhesion, it may not be 
only by homophilic adhesion, but could conceivably bind also to 
another desmosomal transmembrane molecul e. 
In any case we can conclude from these experiments that express-
ing the extracellular region of PV A on the cell surface is not suffi-
cient, in and of itself, to cause strong homophilic adhesion. The 
PV A extracellular domain does mediate weak homophilic adhesion 
and the direct comparison with E-cadherin suggests that the mecha-
nisms of homophilic interactions ofPV A and E-cadherin are differ-
ent and may require different accessory molecules for maximal 
function. 
We thatJk Drs. Masatoshi Takeichi and Norbert FusetJigJor providitJg atJtibodies 
and cells used itJ tllese studies. 
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